ADALIMUMAB
adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe
ADALIMUMAB (12436M)
12436M
Manner of administration:Injection
Restriction 17114
Indication: Severe Crohn disease
Treatment phase: Subsequent continuing treatment of Crohn disease in a paediatric patient
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $624.84 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||